Amgen (AMGN)/Alexion Pharma (NASDAQ: ALXN) engaged in rather protracted and nasty legal fight over biosimilar Soliris in Europe - Adam Feurstein
Related to recent rumors, Adam Feurstein notes Amgen (NASDAQ: AMGN)/Alexion Pharma (NASDAQ: ALXN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)